SOPH (Sophia Genetics) Short-Term Debt : $0.00 Mil (As of Sep. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Sophia Genetics Short-Term Debt?

Sophia Genetics's Short-Term Debt for the quarter that ended in Sep. 2024 was $0.00 Mil.

Sophia Genetics Short-Term Debt Historical Data

The historical data trend for Sophia Genetics's Short-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sophia Genetics Short-Term Debt Chart

Sophia Genetics Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Short-Term Debt

Get a 7-Day Free Trial

2.23

2.87

Sophia Genetics Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Short-Term Debt	Get a 7-Day Free Trial															-	-	-	-	-

Sophia Genetics Short-Term Debt Explanation

Short-Term Debt represents the total amount of Long-Term Debt such as bank loans and commercial paper, which is due within one year.

Sophia Genetics Short-Term Debt Related Terms

Thank you for viewing the detailed overview of Sophia Genetics's Short-Term Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

Sophia Genetics Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Sophia Genetics SA (NAS:SOPH) » Definitions » Short-Term Debt

Comparable Companies

Traded in Other Exchanges

90B:Germany

Address

La Pièce 12, Rolle, CHE, CH-1180

Website

https://www.sophiagenetics.com

Sophia Genetics SA is a healthcare technology company dedicated to establishing the practice of data-driven medicine as the standard of care and for life sciences research. It has built a cloud-based SaaS platform capable of analyzing data and generating insights from complex multimodal data sets and different diagnostic modalities. The Company had a physical presence in three countries outside of its headquarters in Switzerland: France, the United States, and Brazil.